Source: GlobeNewswire

Press Release: Exagen : Exagen Inc. to Participate in Upcoming Investor Conferences

CARLSBAD, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following upcoming investor conferences:

Read full article »
Exagen's Competitors | Exagen's News | Exagen's Financials
Stay up-to-date with the latest news on Exagen
Annual Revenue
$25-100M
Employees
100-250
John Aballi's photo - President & CEO of Exagen

President & CEO

John Aballi

CEO Approval Rating

55/100

Read more
Stay up-to-date with the latest news on Exagen